SONESITATUG VEDOTIN
UNII 96ZG83EF42

Substance Identification & Data

This profile provides standardized clinical and technical data for Sonesitatug Vedotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 96ZG83EF42.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2813237-93-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

96ZG83EF42

CAS Registry Number

2813237-93-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SONESITATUG VEDOTIN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C180413

National Cancer Institute reference terminology for clinical and research data.

INN ID

12846

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-105

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sonesitatug Vedotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SONESITATUG VEDOTIN

Common Names & Synonyms

AN ANTI-CLAUDIN 18.2 MONOCLONAL ANTIBODY CONJUGATED WITH MMAE PAYLOAD

CMG 901 [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(HUMAN CLAUDIN CLDN18) (HUMAN-MUS MUSCULUS MONOCLONAL CM311 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CM311 .KAPPA.-CHAIN, DIMER, THIOETHER WITH N-(((4-((N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)-L-VALYL-N5-(AMINOCARBONYL)-L-ORNITHYL)AMINO)PHENYL)METHOXY)CARBONYL)-N-METHYL-L-VALYL-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-HYDROXY-1-METHYL-2-PHENYLETHYL)AMINO)-1-METHOXY-2-METHYL-3-OXOPROPYL)-1-PYRROLIDINYL)-2-METHOXY-1-((1S)-1-METHYLPROPYL)-4-OXOBUTYL)-N-METHYL-L-VALINAMIDE

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CLDN18 (CLAUDIN 18, CLAUDIN-18, SURFACTANT ASSOCIATED PROTEIN J, SFTPJ) ISOFORM 2), HUMANIZED MONOCLONAL ANTIBODY, CONJUGATED ON AN AVERAGE OF FOUR CYSTEINYL RESIDUES TO VEDOTIN, COMPRISING A CLEAVABLE LINKER AND MONOMETHYLAURISTATIN E (MMAE)

SONESITATUG VEDOTIN [INN]

SONESITATUG VEDOTIN [USAN]